DrugDashboards

Metronidazole

Metronidazole · METRONIDAZOLE 5 mg/mL · Injection, Solution · Intravenous · Hospira, Inc.

NDC 00409-0152-24 · 24 POUCH in 1 CARTON / 1 BAG in 1 POUCH / 100 mL in 1 BAG · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.0330per billing unit (10 MG)HCPCS J1836 · Jul 1, 2026
  • Part D plans paid (avg)$0.0210per dosage unitgross, before rebates — matched by drug name · 2024
  • List price (WAC, as filed)$75.51per packagePfizer · Jan 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$50.68
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$0.033
HCPCS J1836 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$47,859
6,510 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $24.73 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA206191
TE code
AP
Approval date
Feb 25, 2019
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48)Jan 13, 2022
    month 56 — 3× the typical 20-month injectable shortage · model puts 33% odds it resolves within 6 months
  • In shortage now — Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24)Jan 13, 2022
    Other
    month 56 — 3× the typical 20-month injectable shortage · model puts 33% odds it resolves within 6 months
  • In shortage now — Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01)Jan 13, 2022
    Discontinuation of the manufacture of the drug
    month 56 — 3× the typical 20-month injectable shortage · model puts 33% odds it resolves within 6 months
  • In shortage now — Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82)Jan 13, 2022
    Other
    month 56 — 3× the typical 20-month injectable shortage · model puts 33% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Metronidazole (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals Private LimitedMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Civica, Inc.METRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.METRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Hospira, Inc.METRONIDAZOLE 5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.METRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLCMETRONIDAZOLE 500 mg/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Metronidazole — NDC 00409-0152-24," retrieved September 3, 2026, https://drugdashboards.com/drug/00409015224.

Free to cite with attribution — see how the data is put together.